DENGUE VACCINE
* Il prezzo esposto non comprende le spese amministrative della struttura medica
Trade name
Method of administration
It is administered by subcutaneous injection and should not be mixed in the same syringe with other vaccines.
Starting from the age of 4, Qdenga should be administered as a 0.5 ml dose in a two-dose protocol, with a 3-month interval (0 and 3 months). The need for a booster dose has not yet been established.
Side effects and contraindications
The most commonly reported adverse reactions in individuals aged 4 to 60 years include pain at the injection site, headache, muscle pain, redness at the injection site, discomfort, weakness, and fever.
These reactions typically occur within 2 days after injection, are generally mild to moderate in severity, of short duration (1 to 3 days), and less frequent after the second injection.
Contraindications to the vaccine include hypersensitivity after the administration of a previous dose or to a component of the vaccine, congenital or acquired immunodeficiency states, HIV infection, pregnancy, and breastfeeding.
Vaccination with Qdenga should be postponed in individuals with severe acute febrile illness.
Your safety and health are the heart of our commitment.
You can always count on the experience and expertise of the Ambimed team.
Do you need more information or assistance with your booking?
Call your dedicated assistant
+39 02 87399117
Do you find this article interesting? Share it on social networks
